bupropion hydrochloride

Generic: bupropion hydrochloride

Labeler: a-s medication solutions
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name bupropion hydrochloride
Generic Name bupropion hydrochloride
Labeler a-s medication solutions
Dosage Form TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

bupropion hydrochloride 150 mg/1

Manufacturer
A-S Medication Solutions

Identifiers & Regulatory

Product NDC 50090-7422
Product ID 50090-7422_09fd6ebb-17e7-4c6f-998d-289eefc5ba27
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA216800
Listing Expiration 2026-12-31
Marketing Start 2023-05-31

Pharmacologic Class

Classes
aminoketone [epc] dopamine uptake inhibitors [moa] increased dopamine activity [pe] increased norepinephrine activity [pe] norepinephrine uptake inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 500907422
Hyphenated Format 50090-7422

Supplemental Identifiers

RxCUI
993518
UNII
ZG7E5POY8O

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name bupropion hydrochloride (source: ndc)
Generic Name bupropion hydrochloride (source: ndc)
Application Number ANDA216800 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 150 mg/1
source: ndc
Packaging
  • 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-7422-0)
  • 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-7422-1)
  • 180 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-7422-2)
  • 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-7422-3)
source: ndc

Packages (4)

50090-7422-0 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-7422-0) 50090-7422-1 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-7422-1) 50090-7422-2 180 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-7422-2) 50090-7422-3 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-7422-3)

Ingredients (1)

bupropion hydrochloride (150 mg/1)

Linked Drug Pages (1)

Bupropion hydrochloride ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "09fd6ebb-17e7-4c6f-998d-289eefc5ba27", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993518"], "spl_set_id": ["bb63261f-ad18-4885-9ed7-e7dfde33e171"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-7422-0)", "package_ndc": "50090-7422-0", "marketing_start_date": "20241028"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-7422-1)", "package_ndc": "50090-7422-1", "marketing_start_date": "20241028"}, {"sample": false, "description": "180 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-7422-2)", "package_ndc": "50090-7422-2", "marketing_start_date": "20241028"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-7422-3)", "package_ndc": "50090-7422-3", "marketing_start_date": "20241028"}], "brand_name": "Bupropion hydrochloride", "product_id": "50090-7422_09fd6ebb-17e7-4c6f-998d-289eefc5ba27", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "50090-7422", "generic_name": "Bupropion hydrochloride", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion hydrochloride", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA216800", "marketing_category": "ANDA", "marketing_start_date": "20230531", "listing_expiration_date": "20261231"}